Newtyn Management, LLC Abeona Therapeutics Inc. Transaction History
Newtyn Management, LLC
- $517 Million
- Q2 2025
A detailed history of Newtyn Management, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Newtyn Management, LLC holds 480,000 shares of ABEO stock, worth $2.31 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
480,000
Previous 480,000
-0.0%
Holding current value
$2.31 Million
Previous $2.28 Million
19.35%
% of portfolio
0.53%
Previous 0.45%
Shares
2 transactions
Others Institutions Holding ABEO
# of Institutions
101Shares Held
31.4MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$21 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$14.8 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$12.9 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$12.1 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$10.1 Million6.61% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $28.6M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...